
CTT Pharma Corporate Updates
TheNewswire
Published: Aug 12, 2026, 10:20 PM GMT+9
Sentiment Analysis
CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has been looking to acquire a facility for manufacturing and has recently expanded its search for a partnership with a contract manufacturer. CTT is currently engaged in conversations with a contract manufacturer and will update shareholders if an LOI is signed. Additionally, CTT is in advanced contract discussions with an Investor Relations(IR) and a Public Relations(PR) Firm that would handle the company’s future exposure. About CTT Pharmaceutical Holdings, Inc. CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company specializing in oral drug delivery systems designed to provide rapid onset, enhanced patient convenience, and efficient absorption. The Company’s patented micelle based thin film platform is intended to offer a novel alternative to traditional dosage forms across pharmaceutical, therapeutic, and nutraceutical markets. CTT is focused on integrating scientific validation, scalable manufacturing, and regulatory preparedness to support long-term growth and product innovation.
Source: TheNewswire
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.